Castle Biosciences (CSTL.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec17

Castle Biosciences Inc. Announces Superior Performance of Its Product in Predicting Uveal Melanoma Patient Outcomes

12:00

Dec9

Castle Biosciences Inc.'s DecisionDx-Melanoma test receives endorsement from melanoma expert panel

12:01

Nov4

Castle Biosciences released FY2025 Q3 earnings on November 3 After-Market EST, actual revenue USD 83.04 M (forecast USD 71.14 M), actual EPS USD -0.02 (forecast USD -0.5225)

00:00

Castle Biosciences released FY2025 9 Months Earnings on November 3 After-Market EST, with actual revenue of USD 257.22 M and EPS of USD -0.7734

00:00

Oct27

Castle Biosciences to Release FY2025 Q3 Earnings on November 3 After-Market EST, Forecast Revenue USD 71.14 M, EPS USD -0.5225

00:10

Aug28

Castle Biosciences Releases New Evidence Supporting DecisionDx-SCC Test

14:45

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 83.04 M, Net Income -501 K, EPS -0.02

Aug4

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 86.19 M, Net Income 4.523 M, EPS 0.15

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 87.99 M, Net Income -25.85 M, EPS -0.9034

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More